Clinical Trial

SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery

Completed
View on ClinicalTrials.gov →
Summary
This dual-centre, randomized controlled trial evaluates the safety and efficacy of high-purity Type-I collagen-based biomaterial, as a peritoneal substitute following peritonectomy in patients undergoing cytoreductive surgery (CRS) for peritoneal surface malignancy. The study tests whether Surgicoll-Mesh can reduce major postoperative intra-abdominal complications compared with standard management.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-17; most recent amendment 2026-03-27.
Status change: Recruiting → Completed 2026-03-27
Trial Details
NCT Number NCT07241091
Lead Sponsor Adichunchanagiri Institute of Medical Sciences, B G Nagara
Collaborators: JSS Medical College Hospital
Conditions Peritoneal Surface Malignancy, Postoperative Adhesion, Bowel Obstruction, Wound Complications, Surgical Site Infection After Major Surgery, Ovarian Cancer (OvCa)
Enrollment 60 participants
Start Date 2025-10-20
Primary Completion 2026-02-13 (estimated)
Study Completion 2026-02-21 (estimated)
Updated on ClinicalTrials.gov 2026-03-30